MoneyWorks4Me

Brawn Biotech - Quaterly Results

09 Aug 2023 Evaluate
An increase of about 114.20% to Rs. 72.87 millions in the total revenue was observed for the quarter ended June 2023. The total revenue was pegged at Rs. 34.02 millions during the similar quarter previous year.The Net Loss for the quarter ended June 2023 is Rs. -1.72 millions as compared to Net Profit of Rs. 1.31 millions of corresponding quarter ended June 2022Operating profit Margin for the quarter ended June 2023 slipped to -1.55% as compared to 1.77% of corresponding quarter ended June 2022


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202306 202206 % Var 202306 202206 % Var 202303 202203 % Var
Sales 72.87 34.02 114.20 72.87 34.02 114.20 222.31 86.21 157.87
Other Income 0.00 0.00 0.00 0.00 0.00 0.00 0.09 0.03 200.00
PBIDT -1.55 1.77 -187.57 -1.55 1.77 -187.57 -2.94 -20.02 -85.31
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.08 0.63 -87.30
PBDT -1.55 1.77 -187.57 -1.55 1.77 -187.57 -3.02 -20.65 -85.38
Depreciation 0.17 0.23 -26.09 0.17 0.23 -26.09 1.09 0.53 105.66
PBT -1.72 1.54 -211.69 -1.72 1.54 -211.69 -4.11 -21.18 -80.59
TAX 0.00 0.23 0.00 0.00 0.23 0.00 4.57 -4.74 -196.41
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -1.72 1.31 -231.30 -1.72 1.31 -231.30 -8.68 -16.44 -47.20
Equity 30.00 30.00 0.00 30.00 30.00 0.00 30.00 30.00 0.00
PBIDTM(%) -2.13 5.20 -140.88 -2.13 5.20 -140.88 -1.32 -23.22 -94.31
Peers